ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Shital Shrikant Ghogale and Ketaki Niranjan Pathak
Department of Microbiology, Symbiosis Medical College for Women and Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, Maharashtra, India.
Article Number: 11422 | © The Author(s). 2026
J Pure Appl Microbiol. 2026;20(3):2481-2489. https://doi.org/10.22207/JPAM.20.3.44
Received: 10 February 2026 | Accepted: 09 July 2026 | Published online: 01 September 2026
Issue online: September 2026
Abstract

Urinary tract infections are among the most common bacterial infections in clinical practice, and increasing antimicrobial resistance among uropathogens poses a serious challenge to empirical therapy, especially in tertiary care settings. In this study, we analyzed culture positivity rate, bacteriological profile, and distribution of urine isolates by patient location in a tertiary care hospital. This retrospective laboratory-based study was conducted in the Department of Microbiology of a tertiary care teaching hospital between January 2024 and December 2024. Urine samples were processed using standard semiquantitative culture techniques on cystine lactose electrolyte-deficient medium. Organism identification and antimicrobial susceptibility testing were performed using an automated BD Phoenix™ system. Extended-spectrum β-lactamase (ESBL) and carbapenem-resistance detection were interpreted according to Clinical and Laboratory Standards Institute guidelines. Of 3434 urine samples processed, 857 (24.9%) showed significant bacterial growth. Gram-negative bacilli predominated (77.4%), whereas Gram-positive cocci accounted for 22.6%. Culture positivity rate was higher among inpatients than outpatients. Among Gram-negative isolates, ESBL production was most common in Escherichia coli (63.4%; 312/492), and Klebsiella spp. (24.4%; 120/492). Carbapenem-resistant isolates included E. coli (47.4%, 81/171), Klebsiella spp. (28.1%, 48/171), Pseudomonas aeruginosa (14.0%, 24/171), and Acinetobacter spp. (7.0%, 12/171). ESBL producers demonstrated high resistance to cephalosporins and fluoroquinolones, with better susceptibility to nitrofurantoin, amikacin, and meropenem. Colistin retained the highest activity against carbapenem-resistant isolates (81.9%, 140/171). Gram-negative bacilli remain the predominant uropathogens in tertiary care settings, with an increasing burden of ESBL and carbapenem-resistance These findings underscore the need for continuous resistance surveillance, culture-guided therapy, and robust antimicrobial stewardship programs.

Keywords

Urinary Tract Infection, ESBL, Carbapenem-resistance, Uropathogens, Escherichia coli, Antimicrobial Susceptibility, Multidrug-resistant Organisms

Article Metrics

Article View: 134

Share This Article

© The Author(s) 2026. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.